Acute inflammation is a response to an alteration induced by a pathogen or a physical or
chemical insult, which functions to eliminate the source of the damage and restore …

Background: Patient care in ulcerative colitis (UC) remains challenging despite an array of
established treatment options and emerging new therapies. The management of UC therapy …

Objective The aim of this study was to assess the correlation between serum and intestinal
anti-tumour necrosis factor (TNF) levels, and their relationship to endoscopic disease activity …

Sleep disorders have become a global issue, and discovering their causes and
consequences are the focus of many research endeavors. An estimated 70 million …

Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD)
characterized by intestinal inflammation. Increased intestinal levels of the proinflammatory …

Interleukin-33 (IL-33) is a novel member of the interleukin-1 family that induces mucosal
pathology in vivo and may drive fibrosis development and angiogenesis. To address its …

Background We aimed to predict response to biologics in inflammatory bowel disease (IBD)
using computerized image analysis of probe confocal laser endomicroscopy (pCLE) in vivo …

Background One-third of patients with acute severe ulcerative colitis [ASUC] are steroid-
refractory. We aimed to review the different options for the management of steroid-refractory …

Background Acute severe ulcerative colitis (ASUC) is a life‐threatening condition for which
optimal management strategies remain ill‐defined. Aim To review the evidence regarding …

BACKGROUND: Crohn's disease (CD) and ulcerative colitis (UC) have been associated
with a T helper1 (TH1) and a TH2 cytokine profile, respectively. Recently, a TH17 lineage …